Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Boyer

Showing results (221-230 of 223) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 223 results.
Prostate Cancer and Prostatic Diseases|July 20, 2016
A diagnosis of prostate cancer and pursuit of active surveillance is not followed by weight loss: potential for a teachable momentM A Liss, J M Schenk, A V Faino, et al.
Journal of Medicinal Chemistry|March 18, 2015
Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine CarbapenemasesScott J Hecker, K Raja Reddy, Maxim Totrov, et al.
Nature Biotechnology|September 9, 2025
Antibody-bottlebrush prodrug conjugates for targeted cancer therapyBin Liu, Hung V-T Nguyen, Yivan Jiang, et al.
Pageof 23

Showing results (221-230 of 223) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 223 results.
Prostate Cancer and Prostatic Diseases|July 20, 2016
A diagnosis of prostate cancer and pursuit of active surveillance is not followed by weight loss: potential for a teachable momentM A Liss, J M Schenk, A V Faino, et al.
Journal of Medicinal Chemistry|March 18, 2015
Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine CarbapenemasesScott J Hecker, K Raja Reddy, Maxim Totrov, et al.
Nature Biotechnology|September 9, 2025
Antibody-bottlebrush prodrug conjugates for targeted cancer therapyBin Liu, Hung V-T Nguyen, Yivan Jiang, et al.
Pageof 23